Anti-tumour necrosis factor α treatment in chronic recurrent inflammation of the anterior segment of the eye in patients resistant to standard immunomodulatory treatment

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of the rheumatic diseases 2003-12, Vol.62 (12), p.1243-1244
Hauptverfasser: El-Shabrawi, Y, Mangge, H, Hermann, J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1244
container_issue 12
container_start_page 1243
container_title Annals of the rheumatic diseases
container_volume 62
creator El-Shabrawi, Y
Mangge, H
Hermann, J
description
doi_str_mv 10.1136/ard.2003.008615
format Article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1754402</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A111847769</galeid><sourcerecordid>A111847769</sourcerecordid><originalsourceid>FETCH-LOGICAL-b367t-8cc21ccaca0aef07e59b63cc39ac7ca145dc05c80d22f68b0959f9a8edaecce73</originalsourceid><addsrcrecordid>eNqFkk2P0zAQhiMEYsvCmRvyiQNSuna-7FyQqi4LSMvHAfbAxXKdSesltovtoO1f4sYf4TcxJdUWpJVQDklmnvedGXuy7Cmjc8bK5kyFbl5QWs4pFQ2r72UzVjUiL2hD72czipm8aht-kj2K8Rp_qWDiYXaCUFUJXs6yHwuXTJ5G68dAHOjgo4mkVzr5QH79JCmAShZcIsYRvQneGU0C6DGEKdgPylqVjHfE9yRtgCiXIBiUR1j_UR7isIO9yRZhjEZ0wVIJaZI82X90OA0x1o7OW9-Ng8IedscOHmcPejVEeHJ4n2afL159Wr7JLz-8frtcXOarsuEpF1oXTGulFVXQUw51u2pKrctWaa4Vq-pO01oL2hVF34gVbeu2b5WAToHWwMvT7OXkux1XFjqNpYMa5DYYq8JOemXkvxlnNnLtv0vG66qiBRo8PxgE_22EmKQ1UcMwKAd-jJKzilWirBHMJ3CtBpB4lh799BocoK130BsMLxhjouK8aZGf38Hj04E1-k7B2STY32sM0N9OwajcL5DEI5f7BZLTAqHi2d_DH_nDxhx7xruDm9u8Cl9lw0tey_dXS8kK_u7j-dW5_IL8i4lf2ev_Vv8N_5rl1A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71414835</pqid></control><display><type>article</type><title>Anti-tumour necrosis factor α treatment in chronic recurrent inflammation of the anterior segment of the eye in patients resistant to standard immunomodulatory treatment</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>El-Shabrawi, Y ; Mangge, H ; Hermann, J</creator><creatorcontrib>El-Shabrawi, Y ; Mangge, H ; Hermann, J</creatorcontrib><identifier>ISSN: 0003-4967</identifier><identifier>EISSN: 1468-2060</identifier><identifier>DOI: 10.1136/ard.2003.008615</identifier><identifier>PMID: 14644873</identifier><language>eng</language><publisher>England: BMJ Publishing Group Ltd and European League Against Rheumatism</publisher><subject>Care and treatment ; Chronic Disease ; Drug Resistance ; Eye diseases ; HLA-B27 ; HLA-B27 Antigen - analysis ; Humans ; juvenile idiopathic arthritis ; Letter ; Recurrence ; Tumor Necrosis Factor-alpha - antagonists &amp; inhibitors ; tumour necrosis factor α ; Uveitis ; Uveitis, Anterior - drug therapy</subject><ispartof>Annals of the rheumatic diseases, 2003-12, Vol.62 (12), p.1243-1244</ispartof><rights>Copyright 2003 by Annals of the Rheumatic Diseases</rights><rights>COPYRIGHT 2003 BMJ Publishing Group Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-b367t-8cc21ccaca0aef07e59b63cc39ac7ca145dc05c80d22f68b0959f9a8edaecce73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1754402/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1754402/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14644873$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>El-Shabrawi, Y</creatorcontrib><creatorcontrib>Mangge, H</creatorcontrib><creatorcontrib>Hermann, J</creatorcontrib><title>Anti-tumour necrosis factor α treatment in chronic recurrent inflammation of the anterior segment of the eye in patients resistant to standard immunomodulatory treatment</title><title>Annals of the rheumatic diseases</title><addtitle>Ann Rheum Dis</addtitle><subject>Care and treatment</subject><subject>Chronic Disease</subject><subject>Drug Resistance</subject><subject>Eye diseases</subject><subject>HLA-B27</subject><subject>HLA-B27 Antigen - analysis</subject><subject>Humans</subject><subject>juvenile idiopathic arthritis</subject><subject>Letter</subject><subject>Recurrence</subject><subject>Tumor Necrosis Factor-alpha - antagonists &amp; inhibitors</subject><subject>tumour necrosis factor α</subject><subject>Uveitis</subject><subject>Uveitis, Anterior - drug therapy</subject><issn>0003-4967</issn><issn>1468-2060</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkk2P0zAQhiMEYsvCmRvyiQNSuna-7FyQqi4LSMvHAfbAxXKdSesltovtoO1f4sYf4TcxJdUWpJVQDklmnvedGXuy7Cmjc8bK5kyFbl5QWs4pFQ2r72UzVjUiL2hD72czipm8aht-kj2K8Rp_qWDiYXaCUFUJXs6yHwuXTJ5G68dAHOjgo4mkVzr5QH79JCmAShZcIsYRvQneGU0C6DGEKdgPylqVjHfE9yRtgCiXIBiUR1j_UR7isIO9yRZhjEZ0wVIJaZI82X90OA0x1o7OW9-Ng8IedscOHmcPejVEeHJ4n2afL159Wr7JLz-8frtcXOarsuEpF1oXTGulFVXQUw51u2pKrctWaa4Vq-pO01oL2hVF34gVbeu2b5WAToHWwMvT7OXkux1XFjqNpYMa5DYYq8JOemXkvxlnNnLtv0vG66qiBRo8PxgE_22EmKQ1UcMwKAd-jJKzilWirBHMJ3CtBpB4lh799BocoK130BsMLxhjouK8aZGf38Hj04E1-k7B2STY32sM0N9OwajcL5DEI5f7BZLTAqHi2d_DH_nDxhx7xruDm9u8Cl9lw0tey_dXS8kK_u7j-dW5_IL8i4lf2ev_Vv8N_5rl1A</recordid><startdate>200312</startdate><enddate>200312</enddate><creator>El-Shabrawi, Y</creator><creator>Mangge, H</creator><creator>Hermann, J</creator><general>BMJ Publishing Group Ltd and European League Against Rheumatism</general><general>BMJ Publishing Group Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>200312</creationdate><title>Anti-tumour necrosis factor α treatment in chronic recurrent inflammation of the anterior segment of the eye in patients resistant to standard immunomodulatory treatment</title><author>El-Shabrawi, Y ; Mangge, H ; Hermann, J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b367t-8cc21ccaca0aef07e59b63cc39ac7ca145dc05c80d22f68b0959f9a8edaecce73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Care and treatment</topic><topic>Chronic Disease</topic><topic>Drug Resistance</topic><topic>Eye diseases</topic><topic>HLA-B27</topic><topic>HLA-B27 Antigen - analysis</topic><topic>Humans</topic><topic>juvenile idiopathic arthritis</topic><topic>Letter</topic><topic>Recurrence</topic><topic>Tumor Necrosis Factor-alpha - antagonists &amp; inhibitors</topic><topic>tumour necrosis factor α</topic><topic>Uveitis</topic><topic>Uveitis, Anterior - drug therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>El-Shabrawi, Y</creatorcontrib><creatorcontrib>Mangge, H</creatorcontrib><creatorcontrib>Hermann, J</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Annals of the rheumatic diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>El-Shabrawi, Y</au><au>Mangge, H</au><au>Hermann, J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Anti-tumour necrosis factor α treatment in chronic recurrent inflammation of the anterior segment of the eye in patients resistant to standard immunomodulatory treatment</atitle><jtitle>Annals of the rheumatic diseases</jtitle><addtitle>Ann Rheum Dis</addtitle><date>2003-12</date><risdate>2003</risdate><volume>62</volume><issue>12</issue><spage>1243</spage><epage>1244</epage><pages>1243-1244</pages><issn>0003-4967</issn><eissn>1468-2060</eissn><cop>England</cop><pub>BMJ Publishing Group Ltd and European League Against Rheumatism</pub><pmid>14644873</pmid><doi>10.1136/ard.2003.008615</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0003-4967
ispartof Annals of the rheumatic diseases, 2003-12, Vol.62 (12), p.1243-1244
issn 0003-4967
1468-2060
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1754402
source MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection
subjects Care and treatment
Chronic Disease
Drug Resistance
Eye diseases
HLA-B27
HLA-B27 Antigen - analysis
Humans
juvenile idiopathic arthritis
Letter
Recurrence
Tumor Necrosis Factor-alpha - antagonists & inhibitors
tumour necrosis factor α
Uveitis
Uveitis, Anterior - drug therapy
title Anti-tumour necrosis factor α treatment in chronic recurrent inflammation of the anterior segment of the eye in patients resistant to standard immunomodulatory treatment
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T05%3A08%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Anti-tumour%20necrosis%20factor%20%CE%B1%20treatment%20in%20chronic%20recurrent%20inflammation%20of%20the%20anterior%20segment%20of%20the%20eye%20in%20patients%20resistant%20to%20standard%20immunomodulatory%20treatment&rft.jtitle=Annals%20of%20the%20rheumatic%20diseases&rft.au=El-Shabrawi,%20Y&rft.date=2003-12&rft.volume=62&rft.issue=12&rft.spage=1243&rft.epage=1244&rft.pages=1243-1244&rft.issn=0003-4967&rft.eissn=1468-2060&rft_id=info:doi/10.1136/ard.2003.008615&rft_dat=%3Cgale_pubme%3EA111847769%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71414835&rft_id=info:pmid/14644873&rft_galeid=A111847769&rfr_iscdi=true